Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism

ObjectiveSubclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown.DesignOf the 605 subjects consecutively referred for monolateral adrenal incidentalomas (AIs) to our outpatient clinics, 55 SH patients...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of endocrinology Vol. 174; no. 3; pp. 261 - 269
Main Authors Salcuni, Antonio Stefano, Morelli, Valentina, Eller Vainicher, Cristina, Palmieri, Serena, Cairoli, Elisa, Spada, Anna, Scillitani, Alfredo, Chiodini, Iacopo
Format Journal Article
LanguageEnglish
Published England Bioscientifica Ltd 01.03.2016
Subjects
Online AccessGet full text
ISSN0804-4643
1479-683X
1479-683X
DOI10.1530/EJE-15-0977

Cover

Abstract ObjectiveSubclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown.DesignOf the 605 subjects consecutively referred for monolateral adrenal incidentalomas (AIs) to our outpatient clinics, 55 SH patients (recruited on the basis of the exclusion criteria) were enrolled. We suggested to all patients to undergo adrenalectomy, which was accepted by 32 patients (surgical group, age 61.3±8.1 years) and refused by 23 patients, who were followed with a conservative management (non-surgical group, age 65.4±7.1 years).MethodsWe diagnosed SH in patients with serum cortisol after 1 mg dexamethasone suppression test (1 mg-DST) >5.0 μg/dl or with greater than or equal to two criteria among 1 mg-DST >3.0 μg/dl, urinary free cortisol >70 μg/24 h and ACTH <10 pg/ml. We assessed: bone mineral density (BMD) at lumbar spine (LS) and femoral neck (as Z-score) by dual-energy X-ray absorptiometry and the VFx presence by X-ray at baseline and at the end of follow up (surgical group 39.9±20.9 months and non-surgical group 27.7±11.1 months).ResultsThe LS Z-score (ΔZ-score/year) tended to increase in the surgical group (0.10±0.20) compared with the non-surgical group (−0.01±0.27, P=0.08) and in the former, the percentage of patients with new VFx was lower (9.4%) than in the latter (52.2%, P<0.0001). Surgery in AI patients with SH was associated with a 30% VFx risk reduction (odds ratio 0.7, 95% CI 0.01–0.05, P=0.008) regardless of age, gender, follow up duration, 1 mg-DST, LS BMD, and presence of VFx at baseline.ConclusionIn patients with monolateral AI and SH, adrenalectomy reduces the risk of VFx.
AbstractList ObjectiveSubclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown.DesignOf the 605 subjects consecutively referred for monolateral adrenal incidentalomas (AIs) to our outpatient clinics, 55 SH patients (recruited on the basis of the exclusion criteria) were enrolled. We suggested to all patients to undergo adrenalectomy, which was accepted by 32 patients (surgical group, age 61.3±8.1 years) and refused by 23 patients, who were followed with a conservative management (non-surgical group, age 65.4±7.1 years).MethodsWe diagnosed SH in patients with serum cortisol after 1 mg dexamethasone suppression test (1 mg-DST) >5.0 μg/dl or with greater than or equal to two criteria among 1 mg-DST >3.0 μg/dl, urinary free cortisol >70 μg/24 h and ACTH <10 pg/ml. We assessed: bone mineral density (BMD) at lumbar spine (LS) and femoral neck (as Z-score) by dual-energy X-ray absorptiometry and the VFx presence by X-ray at baseline and at the end of follow up (surgical group 39.9±20.9 months and non-surgical group 27.7±11.1 months).ResultsThe LS Z-score (ΔZ-score/year) tended to increase in the surgical group (0.10±0.20) compared with the non-surgical group (−0.01±0.27, P=0.08) and in the former, the percentage of patients with new VFx was lower (9.4%) than in the latter (52.2%, P<0.0001). Surgery in AI patients with SH was associated with a 30% VFx risk reduction (odds ratio 0.7, 95% CI 0.01–0.05, P=0.008) regardless of age, gender, follow up duration, 1 mg-DST, LS BMD, and presence of VFx at baseline.ConclusionIn patients with monolateral AI and SH, adrenalectomy reduces the risk of VFx.
Subclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown. Of the 605 subjects consecutively referred for monolateral adrenal incidentalomas (AIs) to our outpatient clinics, 55 SH patients (recruited on the basis of the exclusion criteria) were enrolled. We suggested to all patients to undergo adrenalectomy, which was accepted by 32 patients (surgical group, age 61.3±8.1 years) and refused by 23 patients, who were followed with a conservative management (non-surgical group, age 65.4±7.1 years). We diagnosed SH in patients with serum cortisol after 1  mg dexamethasone suppression test (1  mg-DST) >5.0  μg/dl or with greater than or equal to two criteria among 1  mg-DST >3.0  μg/dl, urinary free cortisol >70  μg/24  h and ACTH <10  pg/ml. We assessed: bone mineral density (BMD) at lumbar spine (LS) and femoral neck (as Z-score) by dual-energy X-ray absorptiometry and the VFx presence by X-ray at baseline and at the end of follow up (surgical group 39.9±20.9 months and non-surgical group 27.7±11.1 months). The LS Z-score (ΔZ-score/year) tended to increase in the surgical group (0.10±0.20) compared with the non-surgical group (-0.01±0.27, P=0.08) and in the former, the percentage of patients with new VFx was lower (9.4%) than in the latter (52.2%, P<0.0001). Surgery in AI patients with SH was associated with a 30% VFx risk reduction (odds ratio 0.7, 95% CI 0.01-0.05, P=0.008) regardless of age, gender, follow up duration, 1  mg-DST, LS BMD, and presence of VFx at baseline. In patients with monolateral AI and SH, adrenalectomy reduces the risk of VFx.
Subclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown.OBJECTIVESubclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown.Of the 605 subjects consecutively referred for monolateral adrenal incidentalomas (AIs) to our outpatient clinics, 55 SH patients (recruited on the basis of the exclusion criteria) were enrolled. We suggested to all patients to undergo adrenalectomy, which was accepted by 32 patients (surgical group, age 61.3±8.1 years) and refused by 23 patients, who were followed with a conservative management (non-surgical group, age 65.4±7.1 years).DESIGNOf the 605 subjects consecutively referred for monolateral adrenal incidentalomas (AIs) to our outpatient clinics, 55 SH patients (recruited on the basis of the exclusion criteria) were enrolled. We suggested to all patients to undergo adrenalectomy, which was accepted by 32 patients (surgical group, age 61.3±8.1 years) and refused by 23 patients, who were followed with a conservative management (non-surgical group, age 65.4±7.1 years).We diagnosed SH in patients with serum cortisol after 1  mg dexamethasone suppression test (1  mg-DST) >5.0  μg/dl or with greater than or equal to two criteria among 1  mg-DST >3.0  μg/dl, urinary free cortisol >70  μg/24  h and ACTH <10  pg/ml. We assessed: bone mineral density (BMD) at lumbar spine (LS) and femoral neck (as Z-score) by dual-energy X-ray absorptiometry and the VFx presence by X-ray at baseline and at the end of follow up (surgical group 39.9±20.9 months and non-surgical group 27.7±11.1 months).METHODSWe diagnosed SH in patients with serum cortisol after 1  mg dexamethasone suppression test (1  mg-DST) >5.0  μg/dl or with greater than or equal to two criteria among 1  mg-DST >3.0  μg/dl, urinary free cortisol >70  μg/24  h and ACTH <10  pg/ml. We assessed: bone mineral density (BMD) at lumbar spine (LS) and femoral neck (as Z-score) by dual-energy X-ray absorptiometry and the VFx presence by X-ray at baseline and at the end of follow up (surgical group 39.9±20.9 months and non-surgical group 27.7±11.1 months).The LS Z-score (ΔZ-score/year) tended to increase in the surgical group (0.10±0.20) compared with the non-surgical group (-0.01±0.27, P=0.08) and in the former, the percentage of patients with new VFx was lower (9.4%) than in the latter (52.2%, P<0.0001). Surgery in AI patients with SH was associated with a 30% VFx risk reduction (odds ratio 0.7, 95% CI 0.01-0.05, P=0.008) regardless of age, gender, follow up duration, 1  mg-DST, LS BMD, and presence of VFx at baseline.RESULTSThe LS Z-score (ΔZ-score/year) tended to increase in the surgical group (0.10±0.20) compared with the non-surgical group (-0.01±0.27, P=0.08) and in the former, the percentage of patients with new VFx was lower (9.4%) than in the latter (52.2%, P<0.0001). Surgery in AI patients with SH was associated with a 30% VFx risk reduction (odds ratio 0.7, 95% CI 0.01-0.05, P=0.008) regardless of age, gender, follow up duration, 1  mg-DST, LS BMD, and presence of VFx at baseline.In patients with monolateral AI and SH, adrenalectomy reduces the risk of VFx.CONCLUSIONIn patients with monolateral AI and SH, adrenalectomy reduces the risk of VFx.
Author Palmieri, Serena
Cairoli, Elisa
Eller Vainicher, Cristina
Morelli, Valentina
Scillitani, Alfredo
Spada, Anna
Salcuni, Antonio Stefano
Chiodini, Iacopo
Author_xml – sequence: 1
  givenname: Antonio Stefano
  surname: Salcuni
  fullname: Salcuni, Antonio Stefano
– sequence: 2
  givenname: Valentina
  surname: Morelli
  fullname: Morelli, Valentina
– sequence: 3
  givenname: Cristina
  surname: Eller Vainicher
  fullname: Eller Vainicher, Cristina
– sequence: 4
  givenname: Serena
  surname: Palmieri
  fullname: Palmieri, Serena
– sequence: 5
  givenname: Elisa
  surname: Cairoli
  fullname: Cairoli, Elisa
– sequence: 6
  givenname: Anna
  surname: Spada
  fullname: Spada, Anna
– sequence: 7
  givenname: Alfredo
  surname: Scillitani
  fullname: Scillitani, Alfredo
– sequence: 8
  givenname: Iacopo
  surname: Chiodini
  fullname: Chiodini, Iacopo
  email: iacopo.chiodini@policlinico.mi.it
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26630908$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFqFTEUhoNU7G115V6yFHQ0mcxkJstSrlopuFFwN5zJnHBTM8mYZFruK_SpzeVWEYWucuB8-X_4zhk58cEjIS85e8dbwd5vP28r3lZMdd0TsuFNpyrZi-8nZMN61lSNbMQpOUvphjFeZvaMnNZSCqZYvyH3F1NEDw51DvOeRpxWjYnmHdJo0w8aDL3FmHGM4KiJoPMay956ukC26HOidzbv6Bx8cJDxgMExskDaTgUBF2ZIFPxE0zpqZ73VZb3bLxh1iNmm4Gyan5OnBlzCFw_vOfn2Yfv18lN1_eXj1eXFdTUK2edK4VjXUkBba9NxrusOjIapY20_9WBU3cCkR4mm7iUT7dgKoXU9KdWiATUqcU7eHnNXv8D-DpwblmhniPuBs-GgdMAbLMNwUFrw10d8ieHniikPs00anQOPYU0D7yTrVS9EU9BXD-g6zjj9if2tuwBvjoCOIaWI5r_mcsy_mvk_tLa5WA8-R7Du8T-jDUkfDmRNsf1ozy84ZLUw
CitedBy_id crossref_primary_10_1080_17446651_2016_1233055
crossref_primary_10_1016_j_beem_2021_101515
crossref_primary_10_1210_clinem_dgab512
crossref_primary_10_2174_1381612826666200813134328
crossref_primary_10_1515_rjim_2017_0025
crossref_primary_10_1002_agm2_12286
crossref_primary_10_3389_fendo_2022_913253
crossref_primary_10_1016_j_jcte_2018_07_001
crossref_primary_10_1093_ejendo_lvad134
crossref_primary_10_1002_cpt_1551
crossref_primary_10_1016_j_ecl_2018_02_005
crossref_primary_10_1210_endrev_bnaa008
crossref_primary_10_3390_biomedicines12071606
crossref_primary_10_3390_ijms222111521
crossref_primary_10_1016_j_suc_2019_04_011
crossref_primary_10_1007_s12020_019_01888_y
crossref_primary_10_62347_JTQX7232
crossref_primary_10_1016_j_beem_2020_101427
crossref_primary_10_1093_jbmr_zjae067
crossref_primary_10_1016_j_ando_2023_01_005
crossref_primary_10_1016_j_eprac_2021_07_014
crossref_primary_10_1007_s00198_016_3712_6
crossref_primary_10_26442_20751753_2023_4_202306
crossref_primary_10_1210_clinem_dgad560
crossref_primary_10_1097_MED_0000000000000478
crossref_primary_10_3233_CBM_170531
crossref_primary_10_1055_a_1827_4113
crossref_primary_10_1055_a_2329_5787
crossref_primary_10_1007_s12020_018_1696_z
crossref_primary_10_1016_j_cpsurg_2023_101374
crossref_primary_10_1080_17446651_2020_1772051
crossref_primary_10_1007_s12020_019_02066_w
crossref_primary_10_1093_ejendo_lvad066
crossref_primary_10_1001_jamanetworkopen_2024_6453
crossref_primary_10_1007_s40618_020_01484_2
crossref_primary_10_1016_j_beem_2021_101494
crossref_primary_10_1093_ejendo_lvad038
crossref_primary_10_1016_j_beem_2021_101491
crossref_primary_10_3389_fendo_2024_1399311
crossref_primary_10_1210_clinem_dgab698
crossref_primary_10_3389_fendo_2023_1199875
crossref_primary_10_1530_EJE_16_0289
crossref_primary_10_1016_j_surg_2020_05_046
crossref_primary_10_1210_clinem_dgaa120
crossref_primary_10_4158_EP_2019_0047
crossref_primary_10_3390_jcm12134244
crossref_primary_10_1007_s12020_016_1017_3
crossref_primary_10_1007_s12020_025_04203_0
crossref_primary_10_1007_s00108_021_01188_6
crossref_primary_10_1001_jamasurg_2020_3280
crossref_primary_10_5662_wjm_v12_i5_402
crossref_primary_10_1507_endocrj_EJ17_0456
crossref_primary_10_1210_er_2018_00097
crossref_primary_10_4158_DSCR_2018_0565
crossref_primary_10_3389_fendo_2024_1374711
Cites_doi 10.1530/eje.0.1460051
10.1007/s12020-012-9628-9
10.1007/s00198-013-2588-y
10.1210/jc.2010-2722
10.2337/diacare.26.2007.S5
10.1210/jc.87.3.998
10.1210/jc.85.4.1440
10.1097/SLA.0b013e31819a47d2
10.4081/reumatismo.2011.129
10.1210/jc.2009-0468
10.1046/j.1365-2265.2003.01676.x
10.1210/jc.2014-3007
10.1016/j.rcl.2010.02.018
10.1007/s00198-007-0543-5
10.1007/BF03345601
10.1530/EJE-10-1147
10.1210/jc.84.7.2381
10.1007/BF03344099
10.1530/EJE-11-1039
10.1111/j.1365-2265.2010.03794.x
10.1002/jbmr.398
10.1210/jc.2002-020399
10.1001/jama.285.3.320
10.1210/jc.2009-2387
10.1016/j.atherosclerosis.2012.05.007
10.1530/EJE-10-0602
10.1210/jc.85.2.637
doi:0.1002/jbmr.5650080915
10.1016/j.beem.2012.02.001
10.1210/jc.2013-3527
10.1530/EJE-08-0707
10.1530/eje.0.1450241
10.1016/S0889-8529(05)70115-8
10.1016/S2213-8587(13)70211-0
10.1002/jbmr.1648
ContentType Journal Article
Copyright 2016 European Society of Endocrinology
2016 European Society of Endocrinology.
Copyright_xml – notice: 2016 European Society of Endocrinology
– notice: 2016 European Society of Endocrinology.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.1530/EJE-15-0977
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate Fracture risk in subclinical hypercortisolism
EISSN 1479-683X
EndPage 269
ExternalDocumentID 10.1530/eje-15-0977
26630908
10_1530_EJE_15_0977
Genre Clinical Trial
Journal Article
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
5WD
AABZA
AACZT
AAPGJ
AAPXW
AARHZ
AAVAP
AAWDT
ABLYK
ABMNT
ABNHQ
ABOCM
ABPQP
ABPTD
ABSGY
ABSQV
ABWST
ABXVV
ACFRR
ACGFO
ACNCT
ACPRK
ACUTJ
ADBBV
ADDZX
ADIPN
ADQBN
ADVEK
AENEX
AFFNX
AFGWE
AFHIN
AFYAG
AGQXC
AGUTN
AI.
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ANFBD
APJGH
AQVPL
BAWUL
BCRHZ
BTFSW
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
EMOBN
F9R
GX1
HZ~
IL9
INIJC
J5H
KOP
KQ8
L7B
O9-
OAUYM
OBOKY
OCZFY
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
RHF
ROX
SJN
TBS
TCN
TEORI
TMA
TR2
VH1
W8F
WOQ
X7M
ZA5
ZGI
ZXP
AAUAY
AAYXX
ABDFA
ABEJV
ABGNP
ABIME
ABJNI
ABPIB
ABQNK
ABVGC
ABXZS
ADGKP
ADMTO
ADNBA
ADVOB
AEMQT
AFXAL
AHGBF
AHMMS
AJBYB
AJNCP
ALXQX
ATGXG
CITATION
H13
NU-
OBFPC
AGORE
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-b368t-9eb2263a52cf711c27afcad7058d8af924adcb6ef286035b533cc2d995efa9b93
IEDL.DBID UNPAY
ISSN 0804-4643
1479-683X
IngestDate Tue Aug 19 20:17:25 EDT 2025
Sat Sep 27 20:44:08 EDT 2025
Mon Jul 21 06:01:10 EDT 2025
Wed Oct 01 05:54:42 EDT 2025
Thu Apr 24 23:03:57 EDT 2025
Tue Apr 02 06:25:37 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License 2016 European Society of Endocrinology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b368t-9eb2263a52cf711c27afcad7058d8af924adcb6ef286035b533cc2d995efa9b93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://eje.bioscientifica.com/downloadpdf/journals/eje/174/3/261.pdf
PMID 26630908
PQID 1760898334
PQPubID 23479
PageCount 9
ParticipantIDs unpaywall_primary_10_1530_eje_15_0977
proquest_miscellaneous_1760898334
pubmed_primary_26630908
crossref_primary_10_1530_EJE_15_0977
crossref_citationtrail_10_1530_EJE_15_0977
bioscientifica_primary_10_1530_EJE_15_0977
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20160300
2016-03-00
2016-Mar
20160301
PublicationDateYYYYMMDD 2016-03-01
PublicationDate_xml – month: 03
  year: 2016
  text: 20160300
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European journal of endocrinology
PublicationTitleAlternate Eur J Endocrinol
PublicationYear 2016
Publisher Bioscientifica Ltd
Publisher_xml – name: Bioscientifica Ltd
References Diacinti (2016011518231073000_174.3.261.24) 2010; 48
Chiodini (2016011518231073000_174.3.261.31) 2008; 31
2016011518231073000_174.3.261.14
2016011518231073000_174.3.261.36
2016011518231073000_174.3.261.7
2016011518231073000_174.3.261.13
2016011518231073000_174.3.261.8
2016011518231073000_174.3.261.16
2016011518231073000_174.3.261.37
2016011518231073000_174.3.261.18
2016011518231073000_174.3.261.17
Di Dalmazi (2016011518231073000_174.3.261.10) 2014; 2
2016011518231073000_174.3.261.19
De Leo (2016011518231073000_174.3.261.33) 2012; 26
2016011518231073000_174.3.261.30
Giordano (2016011518231073000_174.3.261.6) 2012; 41
2016011518231073000_174.3.261.32
Reincke (2016011518231073000_174.3.261.1) 2000; 29
2016011518231073000_174.3.261.12
2016011518231073000_174.3.261.34
Scillitani (2016011518231073000_174.3.261.28) 2014; 25
Adami (2016011518231073000_174.3.261.25) 2011; 63
Adami (2016011518231073000_174.3.261.26) 2009; 61
Morelli (2016011518231073000_174.3.261.9) 2014; 99
2016011518231073000_174.3.261.2
2016011518231073000_174.3.261.3
2016011518231073000_174.3.261.4
2016011518231073000_174.3.261.5
Morelli (2016011518231073000_174.3.261.35) 2010; 73
2016011518231073000_174.3.261.27
2016011518231073000_174.3.261.29
Chiodini (2016011518231073000_174.3.261.15) 2008; 31
2016011518231073000_174.3.261.21
Debono (2016011518231073000_174.3.261.11) 2014; 99
2016011518231073000_174.3.261.20
2016011518231073000_174.3.261.23
2016011518231073000_174.3.261.22
References_xml – ident: 2016011518231073000_174.3.261.29
  doi: 10.1530/eje.0.1460051
– volume: 41
  start-page: 415
  year: 2012
  ident: 2016011518231073000_174.3.261.6
  article-title: Glucose metabolism in patients with subclinical Cushing's syndrome
  publication-title: Endocrine
  doi: 10.1007/s12020-012-9628-9
– volume: 25
  start-page: 441
  year: 2014
  ident: 2016011518231073000_174.3.261.28
  article-title: Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
  publication-title: Osteoporosis International
  doi: 10.1007/s00198-013-2588-y
– ident: 2016011518231073000_174.3.261.2
  doi: 10.1210/jc.2010-2722
– volume: 61
  start-page: 260
  year: 2009
  ident: 2016011518231073000_174.3.261.26
  article-title: Guidelines for the diagnosis, prevention and treatment of osteoporosis. Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
  publication-title: Reumatismo
– ident: 2016011518231073000_174.3.261.22
  doi: 10.2337/diacare.26.2007.S5
– ident: 2016011518231073000_174.3.261.5
  doi: 10.1210/jc.87.3.998
– ident: 2016011518231073000_174.3.261.7
  doi: 10.1210/jc.85.4.1440
– ident: 2016011518231073000_174.3.261.12
  doi: 10.1097/SLA.0b013e31819a47d2
– volume: 63
  start-page: 129
  year: 2011
  ident: 2016011518231073000_174.3.261.25
  article-title: Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)
  publication-title: Reumatismo
  doi: 10.4081/reumatismo.2011.129
– ident: 2016011518231073000_174.3.261.19
  doi: 10.1210/jc.2009-0468
– ident: 2016011518231073000_174.3.261.34
  doi: 10.1046/j.1365-2265.2003.01676.x
– volume: 99
  start-page: 4462
  year: 2014
  ident: 2016011518231073000_174.3.261.11
  article-title: Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas
  publication-title: Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jc.2014-3007
– volume: 48
  start-page: 561
  year: 2010
  ident: 2016011518231073000_174.3.261.24
  article-title: Vertebral morphometry
  publication-title: Radiologic Clinics of North America
  doi: 10.1016/j.rcl.2010.02.018
– ident: 2016011518231073000_174.3.261.27
  doi: 10.1007/s00198-007-0543-5
– volume: 31
  start-page: 267
  year: 2008
  ident: 2016011518231073000_174.3.261.15
  article-title: Skeletal involvement in adults patients with endogenous hypercortisolism
  publication-title: Journal of Endocrinological Investigation
  doi: 10.1007/BF03345601
– ident: 2016011518231073000_174.3.261.32
  doi: 10.1530/EJE-10-1147
– ident: 2016011518231073000_174.3.261.17
  doi: 10.1210/jc.84.7.2381
– ident: 2016011518231073000_174.3.261.4
  doi: 10.1007/BF03344099
– ident: 2016011518231073000_174.3.261.8
  doi: 10.1530/EJE-11-1039
– volume: 73
  start-page: 161
  year: 2010
  ident: 2016011518231073000_174.3.261.35
  article-title: Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects
  publication-title: Clinical Endocrinology
  doi: 10.1111/j.1365-2265.2010.03794.x
– ident: 2016011518231073000_174.3.261.20
  doi: 10.1002/jbmr.398
– ident: 2016011518231073000_174.3.261.18
  doi: 10.1210/jc.2002-020399
– ident: 2016011518231073000_174.3.261.37
  doi: 10.1001/jama.285.3.320
– ident: 2016011518231073000_174.3.261.13
  doi: 10.1210/jc.2009-2387
– ident: 2016011518231073000_174.3.261.21
  doi: 10.1016/j.atherosclerosis.2012.05.007
– ident: 2016011518231073000_174.3.261.36
  doi: 10.1530/EJE-10-0602
– ident: 2016011518231073000_174.3.261.3
  doi: 10.1210/jc.85.2.637
– ident: 2016011518231073000_174.3.261.23
  doi: doi:0.1002/jbmr.5650080915
– volume: 26
  start-page: 497
  year: 2012
  ident: 2016011518231073000_174.3.261.33
  article-title: Subclinical Cushing's syndrome
  publication-title: Best Practice & Research. Clinical Endocrinology & Metabolism
  doi: 10.1016/j.beem.2012.02.001
– volume: 99
  start-page: 827
  year: 2014
  ident: 2016011518231073000_174.3.261.9
  article-title: Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
  publication-title: Journal of Clinical Endocrinology and Metabolism
  doi: 10.1210/jc.2013-3527
– ident: 2016011518231073000_174.3.261.14
  doi: 10.1530/EJE-08-0707
– ident: 2016011518231073000_174.3.261.16
  doi: 10.1530/eje.0.1450241
– volume: 31
  start-page: 33
  issue: Suppl 7
  year: 2008
  ident: 2016011518231073000_174.3.261.31
  article-title: Densitometry in glucocorticoid-induced osteoporosis
  publication-title: Journal of Endocrinological Investigation
– volume: 29
  start-page: 47
  year: 2000
  ident: 2016011518231073000_174.3.261.1
  article-title: Subclinical Cushing's syndrome
  publication-title: Endocrinology and Metabolism Clinics of North America
  doi: 10.1016/S0889-8529(05)70115-8
– volume: 2
  start-page: 396
  year: 2014
  ident: 2016011518231073000_174.3.261.10
  article-title: Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
  publication-title: Lancet. Diabetes & Endocrinology
  doi: 10.1016/S2213-8587(13)70211-0
– ident: 2016011518231073000_174.3.261.30
  doi: 10.1002/jbmr.1648
SSID ssj0016430
Score 2.4179666
Snippet ObjectiveSubclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is...
Subclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is unknown. Of...
Subclinical hypercortisolism (SH) is associated with increased risk of vertebral fractures (VFx). The effect on bone following recovery from SH is...
SourceID unpaywall
proquest
pubmed
crossref
bioscientifica
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 261
SubjectTerms Absorptiometry, Photon
Adrenal Gland Neoplasms - complications
Adrenal Gland Neoplasms - epidemiology
Adrenal Gland Neoplasms - surgery
Adrenalectomy
Adult
Aged
Asymptomatic Diseases
Bone Density
Clinical Study
Cushing Syndrome - epidemiology
Cushing Syndrome - etiology
Cushing Syndrome - surgery
Female
Femur Neck - diagnostic imaging
Humans
Logistic Models
Lumbar Vertebrae - diagnostic imaging
Male
Middle Aged
Spinal Fractures - epidemiology
Treatment Outcome
Title Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism
URI http://dx.doi.org/10.1530/EJE-15-0977
https://www.ncbi.nlm.nih.gov/pubmed/26630908
https://www.proquest.com/docview/1760898334
https://eje.bioscientifica.com/downloadpdf/journals/eje/174/3/261.pdf
UnpaywallVersion publishedVersion
Volume 174
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1479-683X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016430
  issn: 1479-683X
  databaseCode: KQ8
  dateStart: 19480601
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1479-683X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016430
  issn: 1479-683X
  databaseCode: KQ8
  dateStart: 19970701
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1479-683X
  dateEnd: 20241003
  omitProxy: true
  ssIdentifier: ssj0016430
  issn: 1479-683X
  databaseCode: GX1
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9RAFB7aLSgFb62XFS0jVB-E7CaZZJJ5XGRLqbQouLA-hbnS1Wx22SRI_Qn-as_JZXGtiOBbICdnSHIm-b4553xDyCkX0ionrGd4gKtVkfKkEr4nYqeNjFIVxNgofHnFz2fRxTye75Fp3wtjv9iRWrQ6jk2xjGw-1waV41fSrI0bdw-5RNsxAOoxGwMNGMGpfXLAMc80IAezqw-Tzw2C9CMv4m2hfZQIj6ds3vXpxcxHH14Qez7AoENyb3fk3V_VLfx5SO7WxVrefJN5_ss_6exBWztSNlKGWIrydVRXaqS__yb0-N-3-5Dc71ArnbRh9ojs2eKIHE8KYOzLG_qGNnWkzQL9Eblz2aXrj8mPCfaJyyYzAHYblIm1JQXMSbGkna4cxe2gMXedU4f9WjWwf7ooaCf3WlJcJ6YwVYCBY690TmXrkmKOwLQCREtZUlkYWtaqb_Sk18CvN8CsqwVMrkW5fExmZ9NP7869bvMHTzGeVp4Ayh9yJuNQuyQIdJhIp6VJ_Dg1qXRAG6XRilsXptxnsQLYqnVohIitk0IJ9oQMilVhnxHqQqvABWdaqSg2wPm1jKR2HD3DFUPydvcdZOtW6SNDhgRRkk0vpnCQYZSAcR8Ume5k1HE3j_zPxqdb47_6fNVHVwazG1M2srCrusyChPupSBmLhuRpG3ZbRwCtmC_8dEheb-Pw1igQNP0oz__R7gUZVJvavgSwVakTsv_-Y3rSTaifC6cydQ
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9NAFB7WLigL3na9VFRGWH0Q0iaZzCTzWKTLsrCLDxbqU5grW03T0iTI-hP81Z6TpMW6IoJvgZycIcmZ5PvmnPMNIadCKqe9dIEVEa5WJTpQWoaB5N5YlWQ64tgofHklzmfJxZzPD8h02wvjvriRXnQ6jm2xjGo_1xaV41fKrq0f9w-5QtsxAOoxGwMNGMGpO-RQYJ5pQA5nVx8nn1sEGSZBIrpC-ySVgcjYvO_T4yxEH0HEgxBg0BG5vz_y_q_qFv48Iveacq1uvqmi-OWfdPawqx2pWilDLEX5OmpqPTLffxN6_O_bfUQe9KiVTrowe0wOXHlMTiYlMPblDX1H2zrSdoH-mNy97NP1J-THBPvEVZsZALsNysS6igLmpFjSTlee4nbQmLsuqMd-rQbYP12UtJd7rSiuE1OYKsDAsVe6oKpzSTFHYDsBoqWqqCotrRq9bfSk18CvN8Cs6wVMrkW1fEJmZ9NPH86DfvOHQDOR1YEEyh8LpnhsfBpFJk6VN8qmIc9spjzQRmWNFs7HmQgZ1wBbjYmtlNx5JbVkT8mgXJXuOaE-dhpcCGa0TrgFzm9UoowX6BmuGJL3--8gX3dKHzkyJIiSfHoxhYMcowSMt0GRm15GHXfzKP5sfLoz_qvPN9voymF2Y8pGlW7VVHmUijCTGWPJkDzrwm7nCKAVC2WYDcnbXRzeGgWCZjvKi3-0e0kG9aZxrwBs1fp1P5V-AuKGMYA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adrenalectomy+reduces+the+risk+of+vertebral+fractures+in+patients+with+monolateral+adrenal+incidentalomas+and+subclinical+hypercortisolism&rft.jtitle=European+journal+of+endocrinology&rft.au=Salcuni%2C+Antonio+Stefano&rft.au=Morelli%2C+Valentina&rft.au=Eller+Vainicher%2C+Cristina&rft.au=Palmieri%2C+Serena&rft.date=2016-03-01&rft.eissn=1479-683X&rft.volume=174&rft.issue=3&rft.spage=261&rft_id=info:doi/10.1530%2FEJE-15-0977&rft_id=info%3Apmid%2F26630908&rft.externalDocID=26630908
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon